Lloyd-Smith Malcolm
CIK 0001557146
Chief Regulatory Officer
Filings
4
Latest Feb 8, 2023
Issuers covered
1
Showing
4 of 4
Page 1
Track record
9 of 9 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 9 | 56% | -1.0% | +6.5% | +9.7% | -13.8% |
| 90 days | 9 | 100% | +6.2% | +6.5% | +6.9% | +5.2% |
| 180 days | 9 | 56% | -10.9% | +2.5% | +8.1% | -30.9% |
| 365 days | 9 | 0% | -29.8% | -28.6% | -26.0% | -36.1% |
Issuers
Companies where Lloyd-Smith Malcolm has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 4 | Feb 8, 2023 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|